These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35115106)

  • 1. Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.
    Fiuzat M; Hamo CE; Butler J; Abraham WT; DeFilippis EM; Fonarow GC; Lindenfeld J; Mentz RJ; Psotka MA; Solomon SD; Teerlink JR; Vaduganathan M; Vardeny O; McMurray JJV; O'Connor CM
    J Am Coll Cardiol; 2022 Feb; 79(5):504-510. PubMed ID: 35115106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory.
    Bhatt AS; Abraham WT; Lindenfeld J; Bristow M; Carson PE; Felker GM; Fonarow GC; Greene SJ; Psotka MA; Solomon SD; Stockbridge N; Teerlink JR; Vaduganathan M; Wittes J; Fiuzat M; O'Connor CM; Butler J
    JACC Heart Fail; 2021 Jan; 9(1):1-12. PubMed ID: 33309582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.
    Nguyen E; Weeda ER; White CM
    J Clin Pharmacol; 2016 Aug; 56(8):936-47. PubMed ID: 26626162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Novel Treatment Approaches for Heart Failure With Reduced Ejection Fraction.
    Patel S; Veltri K
    J Pharm Pract; 2017 Oct; 30(5):541-548. PubMed ID: 27194070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Approach to Medical Management of Heart Failure With Reduced Ejection Fraction.
    Miller RJH; Howlett JG; Fine NM
    Can J Cardiol; 2021 Apr; 37(4):632-643. PubMed ID: 33453357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Three-Decade Long Journey in Heart Failure Drug Development.
    Lewis KS; Butler J; Bauersachs J; Sandner P
    Handb Exp Pharmacol; 2017; 243():1-14. PubMed ID: 27995390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.
    McDonald M; Virani S; Chan M; Ducharme A; Ezekowitz JA; Giannetti N; Heckman GA; Howlett JG; Koshman SL; Lepage S; Mielniczuk L; Moe GW; O'Meara E; Swiggum E; Toma M; Zieroth S; Anderson K; Bray SA; Clarke B; Cohen-Solal A; D'Astous M; Davis M; De S; Grant ADM; Grzeslo A; Heshka J; Keen S; Kouz S; Lee D; Masoudi FA; McKelvie R; Parent MC; Poon S; Rajda M; Sharma A; Siatecki K; Storm K; Sussex B; Van Spall H; Yip AMC
    Can J Cardiol; 2021 Apr; 37(4):531-546. PubMed ID: 33827756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Natriuretic Peptide Levels in Heart Failure with Therapy: Does "X" Really Mark the Spot?
    Logan JK; Mentz RJ
    Curr Heart Fail Rep; 2019 Dec; 16(6):250-256. PubMed ID: 31741230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic heart failure: what does the horizon look like?
    Estep JD
    Curr Opin Cardiol; 2015 Jul; 30(4):344-53. PubMed ID: 26049379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feature and impact of guideline-directed medication prescriptions for heart failure with reduced ejection fraction accompanied by chronic kidney disease.
    Chen YL; Hang CL; Su CH; Wu PJ; Chen HC; Fang HY; Fang YN; Cheng CI; Fu M; Chen SM
    Int J Med Sci; 2021; 18(12):2570-2580. PubMed ID: 34104088
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
    Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
    JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction.
    Straw S; McGinlay M; Witte KK
    Open Heart; 2021 Mar; 8(1):. PubMed ID: 33653703
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.
    Lewis GD; Voors AA; Cohen-Solal A; Metra M; Whellan DJ; Ezekowitz JA; Böhm M; Teerlink JR; Docherty KF; Lopes RD; Divanji PH; Heitner SB; Kupfer S; Malik FI; Meng L; Wohltman A; Felker GM
    JAMA; 2022 Jul; 328(3):259-269. PubMed ID: 35852527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic Management for Heart Failure and Emerging Therapies.
    Kim DH; Chien FJ; Eisen HJ
    Curr Cardiol Rep; 2017 Aug; 19(10):94. PubMed ID: 28840572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction.
    Talha KM; Butler J
    Clin Cardiol; 2022 Jun; 45 Suppl 1(Suppl 1):S31-S39. PubMed ID: 35789018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Current Focus of Heart Failure Clinical Trials.
    Pothineni NV; Kattoor AJ; Kovelamudi S; Kenchaiah S
    J Card Fail; 2018 May; 24(5):321-329. PubMed ID: 29482028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing New Treatments for Heart Failure: Focus on the Heart.
    Gheorghiade M; Larson CJ; Shah SJ; Greene SJ; Cleland JG; Colucci WS; Dunnmon P; Epstein SE; Kim RJ; Parsey RV; Stockbridge N; Carr J; Dinh W; Krahn T; Kramer F; Wahlander K; Deckelbaum LI; Crandall D; Okada S; Senni M; Sikora S; Sabbah HN; Butler J
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs and devices in the pipeline for heart failure with reduced ejection fraction versus heart failure with preserved ejection fraction.
    Raina A; Kanwar M
    Curr Heart Fail Rep; 2014 Dec; 11(4):374-81. PubMed ID: 25212250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.